当前位置:首页 - 行情中心 - 双鹭药业(002038) - 财务分析 - 现金流量表

双鹭药业

(002038)

  

流通市值:55.63亿  总市值:67.09亿
流通股本:8.52亿   总股本:10.27亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金234,161,730.03706,218,709.51,148,962,111.33727,716,051.46
  收到的税费返还4,714.836,677,353.56,682,168.726,542,131.3
  收到其他与经营活动有关的现金2,667,964.47624,924,602.0311,095,125.971,787,167.44
  经营活动现金流入小计236,834,409.331,337,820,665.031,166,739,406.02736,045,350.2
  购买商品、接受劳务支付的现金102,236,964.14106,189,885.85941,881,923.99650,341,221.74
  支付给职工以及为职工支付的现金40,053,010.36132,206,662.43102,694,043.572,025,964.86
  支付的各项税费12,336,587.9833,278,961.8621,679,589.915,004,860.35
  支付其他与经营活动有关的现金23,552,165.2808,481,885.76106,315,586.9371,057,177.26
  经营活动现金流出小计178,178,727.681,080,157,395.91,172,571,144.32808,429,224.21
  经营活动产生的现金流量净额58,655,681.65257,663,269.13-5,831,738.3-72,383,874.01
二、投资活动产生的现金流量:
  收回投资收到的现金120,000,000319,824,722.2250,000,000250,000,000
  取得投资收益收到的现金12,359,242.746,237,584.8924,553,591.7122,126,141.32
  处置固定资产、无形资产和其他长期资产收回的现金净额-600--
  收到的其他与投资活动有关的现金-37,812.32--
  投资活动现金流入小计132,359,242.7366,100,719.41274,553,591.71272,126,141.32
  购建固定资产、无形资产和其他长期资产支付的现金6,378,662.71192,971,730.61155,025,786.75143,680,278.07
  投资支付的现金100,000,000293,427,030130,000,000130,000,000
  支付其他与投资活动有关的现金-18,982,609.39--
  投资活动现金流出小计106,378,662.71505,381,370285,025,786.75273,680,278.07
  投资活动产生的现金流量净额25,980,579.99-139,280,650.59-10,472,195.04-1,554,136.75
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金50,000,000---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计50,000,000---
  分配股利、利润或偿付利息支付的现金-17,895,318.8620,547,000-
  筹资活动现金流出平衡项目-00-
  筹资活动现金流出小计-17,895,318.8620,547,000-
  筹资活动产生的现金流量净额平衡项目000-
  筹资活动产生的现金流量净额50,000,000-17,895,318.86-20,547,000-
四、汇率变动对现金及现金等价物的影响-9.676.7311.4414.67
五、现金及现金等价物净增加额134,636,251.97100,487,306.41-36,850,921.9-73,937,996.09
  加:期初现金及现金等价物余额500,365,555.38399,878,248.97399,878,248.97399,878,248.97
  期末现金及现金等价物余额635,001,807.35500,365,555.38363,027,327.07325,940,252.88
补充资料:
  净利润--348,208,492.02-120,622,869.06
  资产减值准备-27,461,410.02-378,150.19
  固定资产和投资性房地产折旧-42,302,530.75-21,040,748.55
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-42,302,530.75-21,040,748.55
  无形资产摊销-124,481,490.29-61,973,612.99
  长期待摊费用摊销-278,940.16-139,470.08
  处置固定资产、无形资产和其他长期资产的损失-46,020.43--403.03
  固定资产报废损失--754.65--
  公允价值变动损失--353,806,373.8--110,052,337.21
  投资损失--13,380,373.66--10,278,335.2
  递延所得税-63,687,549.96-15,310,578.44
  其中:递延所得税资产减少-15,822,496.93-5,149,015.58
    递延所得税负债增加-47,865,053.03-10,161,562.86
  存货的减少--436,264,537.82--169,086,510.53
  经营性应收项目的减少--14,764,199.16-24,796,734.15
  经营性应付项目的增加-544,683,193.85--27,228,451.5
  其他-621,146,864.78--
  现金的期末余额-500,365,555.38-325,940,252.88
  减:现金的期初余额-399,878,248.97-399,878,248.97
  现金及现金等价物的净增加额-100,487,306.41--73,937,996.09
公告日期2026-04-292026-04-292025-10-272025-08-26
审计意见(境内)标准无保留意见
TOP↑